Work

Real-world post-APT trial adoption of de-escalated systemic therapy and outcomes in small HER2-positive breast cancer: An NCDB analysis.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.539

Authors: Mengni Guo, Darren Wijaya, Ami Patel, Roshni Narurkar, Gayathri Nagaraj

Institutions: Loma Linda University Medical Center, Loma Linda University, Loma Linda University Health Care

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162514402

Cites:

Cited by:

Related to: